In this episode of the Life Science Success podcast, my guest is Martin-Immanuel Bittner ππ πππ©πͺπ ππππ. Martin-Immanuel is the CEO & Co-Founder of Arctoris, a biotech platform company powered by robotics and machine learning based in Oxford and Boston.
Martin-Immanuel Bittner is the CEO and founder of Arctoris, a biotech platform company focused on drug discovery with partnerships worldwide.
Martin-Immanuel Bittner is the CEO and founder of Arctoris, a biotech platform company powered by robotics and machine learning based in Oxford and Boston The company's focus is on drug discovery, and it has partnerships with dozens of biotech and pharma companies worldwide The company is actively hiring and anticipates continued revenue growth and team growth in the coming years Bittner is excited about the continued drive towards having physiologically more relevant model systems Bittner sees AI and machine learning as powerful tools that will be increasingly adopted in a drug discovery context and predicts that all drugs reaching the market will have had some form of AI involvement in the future Bittner is concerned about human health being jeopardized by conflicts between different geopolitical blocks and the risk management that companies need to consider Bittner is excited about the transformation of the industry and the opportunities that lie ahead with new technologies and techniques that can bring more and better drugs to patients faster
